09
Nov

Byetta Side Effects: FDA Issues New Warnings On Diabetes Drug

Byetta aka Exenatide: Reports from diabetics of kidney problems & renal failure prompt new warnings from U.S. Food and Drug Administration on diabetes drug.
The U.S. Food and Drug Administration (FDA) has approved new language to be included on the drug label of popular diabetes medication Byetta, also known as exenatide. The new language will include [...]

06
May

FDA extended time to review saxagliptin for treatment of diabetes

Endocrine Today, NJ
The Food and Drug Administration has extended the date of the Prescription Drug User Fee Act from April 30, 2009 to July 30, 2009, stating that additional time is needed to complete the review of saxagliptin for the treatment of Type Two Diabetes.

Topics: type two diabetes, prescription, diabetes, News, Saxagliptin, Drug, type two, AstraZeneca, [...]

06
May

FDA delays decision on diabetes treatment Onglyza

BusinessWeek
Drugmakers Bristol-Myers Squibb Co. and AstraZeneca PLC said Thursday federal regulators need more time to review their application for the Diabetes treatment Onglyza. The Food and Drug Administration has extended its deadline for making a decision on …

Topics: cells, diabetes, FDA, AstraZeneca, Drug, Saxagliptin, treatment, food and drug administration, News, fitness

Related Articles

FDA extended time to [...]

06
May

Amylin seeks FDA OK on once-weekly diabetes drug

AP
Biotechnology company Amylin Pharmaceuticals Inc. said Tuesday it asked the Food and Drug Administration to approve its highly anticipated once-weekly injectable Diabetes treatment exenatide LAR.

Topics: diabetes drug, FDA, health, Drug, diabetes, treatment, News, food and drug administration

Related Articles

FDA: Bristol-Myers diabetes drug appears safe (AP)
New Diabetes Drugs In the Pipeline
FDA: Bristol-Myers diabetes drug appears safe
Update On [...]